Login
$INCY
$116.77 -$0.10 (0.09%) Live

$INCY SEC Filings

Filed On Filing
29 Oct 2026 10-Q
29 Oct 2026 8-K: Results of Operations and Financial Condition

Date of Report (Date of earliest event reported): October 29, 2026

19 Oct 2026 Form 4: Cagnoni Pablo J, President, Global Head of R&D

Received 2,642 shares by exercise or conversion ($174K) · Sold 2,642 shares ($298K)

15 Oct 2026 144
05 Oct 2026 Form 4: Heeson Lee, EVP, Head of Incyte Intl

Gave up 463 shares to cover exercise price or tax ($54.2K)

02 Oct 2026 Form 4: Clancy Paul J, Director

Received 203 shares as a grant or award ($24.6K)

02 Oct 2026 Form 4: Baker Bros. Advisors Lp, Director and 5 others

Received 644 shares as a grant or award

02 Oct 2026 Form 4: Harrigan Edmund, Director

Received 206 shares as a grant or award ($25K)

24 Sep 2026 Form 4: Gardner David H, EVP, Chief Strategy Officer

Gave up 920 shares to cover exercise price or tax ($117K)

17 Sep 2026 Form 4: Cagnoni Pablo J, President, Global Head of R&D

Received 23,218 shares by exercise or conversion ($1.54M) · Sold 23,218 shares ($2.8M)

15 Sep 2026 144
31 Aug 2026 8-K: Other Events
27 Aug 2026 Form 4: Basi Ramitpal K, EVP, Human Resources

Gave up 504 shares to cover exercise price or tax ($65.4K)

20 Aug 2026 Form 4: Cagnoni Pablo J, President, Global Head of R&D

Sold 10,801 shares ($1.36M)

19 Aug 2026 144
14 Aug 2026 Form 4: Cagnoni Pablo J, President, Global Head of R&D

Sold 10,803 shares ($1.3M)

12 Aug 2026 144
07 Aug 2026 Form 4: Cagnoni Pablo J, President, Global Head of R&D

Sold 10,640 shares ($1.31M)

07 Aug 2026 Form 4: Mayes Patrick A, EVP & Chief Scientific Officer

Received 2,207 shares by exercise or conversion ($235K) · Sold 2,207 shares ($274K)

05 Aug 2026 144

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support